Stay updated on Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a maintenance update to the page. This change does not modify the study details or other substantive content on the page.
    Difference
    0.1%
    Check dated 2026-06-08T05:07:10.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    - The related topics section no longer lists Melanoma and the MedlinePlus Genetics entry.
    Difference
    0.2%
    Check dated 2026-06-01T02:59:33.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision on the page updated from v3.5.3 to v3.5.4, signaling a small patch or administrative update to the page metadata. No changes to the study content or user-facing information are indicated.
    Difference
    0.1%
    Check dated 2026-05-17T09:11:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Melanoma is added as a study topic and a Related topics section includes MedlinePlus Genetics, broadening navigational connections to related consumer health resources. These additions also connect the study to genetics information relevant to the condition.
    Difference
    0.2%
    Check dated 2026-05-10T08:54:21.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page header/footer was updated to a new site software revision version (v3.5.3 instead of v3.5.2) without any accompanying changes to the study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:31:54.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2. Melanoma and the related topic MedlinePlus Genetics, along with the Revision: v3.5.0 reference, were removed.
    Difference
    0.2%
    Check dated 2026-04-18T13:21:07.000Z thumbnail image

Stay in the know with updates to Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.